These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


325 related items for PubMed ID: 18387818

  • 1. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
    Aguib Y, Gilch S, Krammer C, Ertmer A, Groschup MH, Schätzl HM.
    Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
    [Abstract] [Full Text] [Related]

  • 2. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y, Han B, Titlow W, Mays CE, Kwon M, Ryou C.
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [Abstract] [Full Text] [Related]

  • 3. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M, Kehler C, Maas E, Kassack MU, Groschup M, Schätzl HM.
    J Cell Sci; 2005 Nov 01; 118(Pt 21):4959-73. PubMed ID: 16219680
    [Abstract] [Full Text] [Related]

  • 4. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
    Gilch S, Nunziante M, Ertmer A, Schätzl HM.
    Vet Microbiol; 2007 Aug 31; 123(4):377-86. PubMed ID: 17493775
    [Abstract] [Full Text] [Related]

  • 5. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
    Pfeifer A, Eigenbrod S, Al-Khadra S, Hofmann A, Mitteregger G, Moser M, Bertsch U, Kretzschmar H.
    J Clin Invest; 2006 Dec 31; 116(12):3204-10. PubMed ID: 17143329
    [Abstract] [Full Text] [Related]

  • 6. Selective re-routing of prion protein to proteasomes and alteration of its vesicular secretion prevent PrP(Sc) formation.
    Filesi I, Cardinale A, Mattei S, Biocca S.
    J Neurochem; 2007 Jun 31; 101(6):1516-26. PubMed ID: 17542810
    [Abstract] [Full Text] [Related]

  • 7. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
    Pimpinelli F, Lehmann S, Maridonneau-Parini I.
    Eur J Neurosci; 2005 Apr 31; 21(8):2063-72. PubMed ID: 15869502
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia-inducible factor-1 α regulates prion protein expression to protect against neuron cell damage.
    Jeong JK, Seo JS, Moon MH, Lee YJ, Seol JW, Park SY.
    Neurobiol Aging; 2012 May 31; 33(5):1006.e1-10. PubMed ID: 22036844
    [Abstract] [Full Text] [Related]

  • 9. Prion infection of differentiated neurospheres.
    Herva ME, Relaño-Ginés A, Villa A, Torres JM.
    J Neurosci Methods; 2010 May 15; 188(2):270-5. PubMed ID: 20206206
    [Abstract] [Full Text] [Related]

  • 10. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.
    Enari M, Flechsig E, Weissmann C.
    Proc Natl Acad Sci U S A; 2001 Jul 31; 98(16):9295-9. PubMed ID: 11470893
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
    White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, Anstee D, Collinge J, Hawke S.
    Nature; 2003 Mar 06; 422(6927):80-3. PubMed ID: 12621436
    [Abstract] [Full Text] [Related]

  • 13. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
    Dupiereux I, Zorzi W, Rachidi W, Zorzi D, Pierard O, Lhereux B, Heinen E, Elmoualij B.
    J Neurosci Res; 2006 Aug 15; 84(3):637-46. PubMed ID: 16786576
    [Abstract] [Full Text] [Related]

  • 14. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX, Li C, Sy MS, Wong BS.
    J Neurochem; 2007 Feb 15; 100(3):841-54. PubMed ID: 17144900
    [Abstract] [Full Text] [Related]

  • 15. Antiprion properties of prion protein-derived cell-penetrating peptides.
    Löfgren K, Wahlström A, Lundberg P, Langel U, Gräslund A, Bedecs K.
    FASEB J; 2008 Jul 15; 22(7):2177-84. PubMed ID: 18296502
    [Abstract] [Full Text] [Related]

  • 16. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
    Sakudo A, Wu G, Onodera T, Ikuta K.
    Biochem Biophys Res Commun; 2008 Jan 04; 365(1):164-9. PubMed ID: 17981146
    [Abstract] [Full Text] [Related]

  • 17. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy.
    Heiseke A, Aguib Y, Riemer C, Baier M, Schätzl HM.
    J Neurochem; 2009 Apr 04; 109(1):25-34. PubMed ID: 19183256
    [Abstract] [Full Text] [Related]

  • 18. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
    Iwamaru Y, Shimizu Y, Imamura M, Murayama Y, Endo R, Tagawa Y, Ushiki-Kaku Y, Takenouchi T, Kitani H, Mohri S, Yokoyama T, Okada H.
    J Neurochem; 2008 Nov 04; 107(3):636-46. PubMed ID: 18717818
    [Abstract] [Full Text] [Related]

  • 19. Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP.
    Rambold AS, Miesbauer M, Olschewski D, Seidel R, Riemer C, Smale L, Brumm L, Levy M, Gazit E, Oesterhelt D, Baier M, Becker CF, Engelhard M, Winklhofer KF, Tatzelt J.
    J Neurochem; 2008 Oct 04; 107(1):218-29. PubMed ID: 18691383
    [Abstract] [Full Text] [Related]

  • 20. Specific inhibition of pathological prion protein accumulation by small interfering RNAs.
    Daude N, Marella M, Chabry J.
    J Cell Sci; 2003 Jul 01; 116(Pt 13):2775-9. PubMed ID: 12759373
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.